Concepedia

Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients

Habib Ghaznavi, Zahra Mohammadghasemipour, Milad Shirvaliloo, Mohammad Kazem Momeni, Maliheh Metanat, Farzaneh Gorgani, Fatemeh Abedipour, Mahdi Mohammadi, Majid Sartipi, Ali Reza Salimi Khorashad,

Inflammopharmacology · 2022 · 19 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Nitric oxide activates cyclooxygenase enzymes.

Daniela Salvemini, Thomas P. Misko, Jaime L. Masferrer et al. · Proceedings of the National Academy of Sciences · 1993 · 1.4K citations

, , +13

Randomization in Clinical Trials

Kristine Broglio · JAMA · 2018 · 251 citations

, , +11

Indomethacin Has a Potent Antiviral Activity against Sars Coronavirus

Carla Amici, Antonino Di, Alessandra Ciucci et al. · Antiviral Therapy · 2006 · 214 citations · Full text

, , +17

Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition

Aleix Gimeno, Júlia Mestres‐Truyol, María José Ojeda et al. · International Journal of Molecular Sciences · 2020 · 168 citations · Full text

, , +17

Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: Results of a randomized double-blind trial

Francis K.L. Chan, Lawrence C.T. Hung, Bing Yee Suen et al. · Gastroenterology · 2004 · 157 citations · Full text

, , +7